Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Febuxostat (120mg) Tablet
Therapeutic Category
Orthopedics, Urology
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Febuglit 120 Tablet containing Febuxostat is used for the management of elevated uric acid levels and gout-related conditions. It helps reduce uric acid production and supports long-term metabolic and joint health.
Febuxostat works as a xanthine oxidase inhibitor, which decreases the formation of uric acid in the body, helping prevent gout attacks and urate crystal buildup in joints.
The tablet is widely prescribed in rheumatology and general medicine practice for chronic gout and hyperuricemia management, leading to consistent prescription demand.
With increasing lifestyle-related metabolic disorders and growing demand for effective uric acid-lowering therapies, this product offers strong business potential for retailers and distributors. Its established clinical effectiveness, strong therapeutic relevance, and steady market demand make it a reliable product for growth in the rheumatology segment.
Some patients may experience nausea, liver function abnormalities, headache, rash, diarrhea, or dizziness. Rarely, serious cardiovascular events, severe hypersensitivity reactions, or liver toxicity may occur and require immediate medical attention.
Febuglit 120 Tablet is indicated for chronic gout, hyperuricemia, gouty arthritis, and conditions associated with elevated uric acid levels. It helps maintain normal uric acid levels, prevent gout flare-ups, and reduce joint inflammation caused by urate crystal deposition.
This medicine should be used strictly under medical supervision. Regular monitoring of liver function and uric acid levels may be required during treatment. It is not intended for the treatment of acute gout attacks. Use cautiously in patients with cardiovascular disease, liver impairment, or kidney disorders.
Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.
Composition : Febuxostat (80mg) Tablet
Composition : Allopurinol (300mg) Tablet
Composition : Allopurinol (100mg) Tablet
Composition : Esomeprazole (40mg)
Composition : Febuxostat (40mg) Tablet
Composition : Domperidone (10mg) + Pantoprazole (40mg)
Composition : Domperidone (10mg) + Rabeprazole (20mg)
Composition : Ondansetron (4mg) + Rabeprazole (20mg)
Composition : Domperidone (30mg) + Rabeprazole (20mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Febuxostat 120mg Tablet has strong demand in the rheumatology, orthopedics, and chronic care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on gout management and metabolic disorder portfolios.
Medical distributors and agencies can benefit from consistent demand for hyperuricemia and gout management under medical supervision. Febuxostat 120mg is a xanthine oxidase inhibitor that helps reduce uric acid production in the body Commonly prescribed for chronic hyperuricemia in patients with gout and gout-related complications Helps maintain healthy uric acid levels and reduce the risk of recurrent gout attacks Widely prescribed by rheumatologists, orthopedic specialists, nephrologists, and general physicians Higher-strength formulation is suitable for patients requiring intensive uric acid control as determined by healthcare professionals This strengthens a comprehensive rheumatology and chronic care portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Febuxostat 120mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from steady prescription demand, long-term therapy usage, repeat orders, reliable supply chain support, and attractive margins in the gout management and metabolic care segment.
Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to explore PCD pharma franchise opportunities, discuss pricing and business terms, obtain monopoly territory rights, and benefit from comprehensive marketing support, quality pharmaceutical products, and a dependable supply chain to grow their business successfully.